BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8608962)

  • 21. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues.
    Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y
    Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
    Rots MG; Pieters R; Peters GJ; Noordhuis P; Van Zantwijk CH; Henze G; Janka-Schaub GE; Veerman AJ; Jansen G
    Br J Haematol; 2000 Jun; 109(3):629-34. PubMed ID: 10886214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confocal microscopy visualization of antifolate uptake by the reduced folate carrier in human leukaemic cells.
    Jolivet J; Faure MP; Wong SC; Taub JW; Matherly LH
    Br J Cancer; 1997; 76(6):734-8. PubMed ID: 9310238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional aspects of membrane folate receptors in human breast cancer cells with transport-related resistance to methotrexate.
    Pinard MF; Jolivet J; Ratnam M; Kathmann I; Molthoff C; Westerhof R; Schornagel JH; Jansen G
    Cancer Chemother Pharmacol; 1996; 38(3):281-8. PubMed ID: 8646804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias.
    Longo GS; Gorlick R; Tong WP; Lin S; Steinherz P; Bertino JR
    Oncol Res; 1997; 9(5):259-63. PubMed ID: 9306433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines.
    McCloskey DE; McGuire JJ; Russell CA; Rowan BG; Bertino JR; Pizzorno G; Mini E
    J Biol Chem; 1991 Apr; 266(10):6181-7. PubMed ID: 2007575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifolate resistance and its circumvention by new analogues.
    Takemura Y; Kobayashi H; Miyachi H
    Hum Cell; 2001 Sep; 14(3):185-202. PubMed ID: 11774738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
    Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
    McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
    Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
    Pizzorno G; Chang YM; McGuire JJ; Bertino JR
    Cancer Res; 1989 Oct; 49(19):5275-80. PubMed ID: 2475246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid decline in folylpolyglutamate synthetase activity and gene expression during maturation of HL-60 cells. Nature of the effect, impact on folate compound polyglutamate pools, and evidence for programmed down-regulation during maturation.
    Egan MG; Sirlin S; Rumberger BG; Garrow TA; Shane B; Sirotnak FM
    J Biol Chem; 1995 Mar; 270(10):5462-8. PubMed ID: 7890662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the study of rTS proteins. rTS expression during growth and in response to thymidylate synthase inhibitors in human tumor cells.
    Dolnick BJ; Lu K; Yin MB; Rustum YM
    Adv Enzyme Regul; 1997; 37():95-109. PubMed ID: 9381988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates.
    Barakat RR; Li WW; Lovelace C; Bertino JR
    Gynecol Oncol; 1993 Oct; 51(1):54-60. PubMed ID: 7694891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines.
    Drake JC; Allegra CJ; Moran RG; Johnston PG
    Biochem Pharmacol; 1996 May; 51(10):1349-55. PubMed ID: 8787551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.
    Rots MG; Willey JC; Jansen G; Van Zantwijk CH; Noordhuis P; DeMuth JP; Kuiper E; Veerman AJ; Pieters R; Peters GJ
    Leukemia; 2000 Dec; 14(12):2166-75. PubMed ID: 11187907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.